Calprotectin Home Testing

Introducing Patient Home Tests for Calprotectin in a Routine District General Hospital

IBDoc

Gastrointestinal/IBD Nurse of the Year 2018 introduces calprotectin home testing at her hospital. Pearl Avery of Dorset County Hospital NHS Trust has been awarded Gastrointestinal/IBD Nurse of the Year 2018 for her pioneering work to introduce a new IBD patient management system which has earned national recognition. It incorporates the IBD registry and the BÜHLMANN IBDoc calprotectin home test. In this article Pearl…

From BÜHLMANN Quantum Blue® to fCAL turbo®

fCAL turbo, Quantum Blue

Follow the Evolution of Calprotectin Testing at James Cook University Hospital This interview with Mr Andrew Teggert, Clinical Scientist, James Cook University Hospital, Middlesbrough, discusses recent changes made to the faecal calprotectin testing at the largest hospital in Tees Valley, which serves around 1.5 million patients. With a growing demand for calprotectin testing and the need for a wider…

Uganda_Case_Study

Out of Africa: Using Faecal Calprotectin Assays in the African Setting and Screening for Intestinal Schistosomiasis

Quantum Blue

Professor Russell Stothard and Dr Amaya Bustinduy Liverpool School of Tropical Medicine, London School of Hygiene and Tropical Medicine Our article highlights ongoing work in Uganda measuring morbidity associated with intestinal schistosomiasis using faecal calprotectin tests. Our original study was as first reported in PLOS NTDs see http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0002542 Expanded access to point-of-care tests (POC) is important for…

Dorset-County-Hospital

IBDoc®: Early Value in a District General Hospital Inflammatory Bowel Disease Service

IBDoc

At the European Crohn’s and Colitis Organisation, 13th Congress in Vienna in February 2018 Avery and Wilson of Dorset County Hospital Foundation Trust, Gastroenterology, Dorchester, UK presented the poster: IBDoc® Self-care/Point of care Calprotectin Test: Early Value in a District General Hospital Inflammatory Bowel Disease Service. This describes a study using the BÜHLMANN IBDoc® calprotectin test in comparison to a send…

Table1_Calprotectin-and-Clinical-Correlation

Calprotectin and Clinical Correlation

fCAL turbo

Mary O’Connell née Deasy, Biochemistry Department, Mercy University Hospital, Cork In issue 2017-3 of Leading Edge, Mary O’Connell detailed her evaluation of the BÜHLMANN fCAL® turbo assay on the Abbott Architect C8000 analyser in comparison to the Phadia 250 ELiA™ Fluorenzyme-Immunoassay. Data was collected from 60 patient faecal samples that were tested for calprotectin concentrations using both methods. All 60 results from the…

Cost Effective Monitoring

IBDoc

Using IBDoc Faecal Calprotectin Testing Post Induction of anti-TNF Therapy G. Elsafi et al. Department of Gastroenterology, Mercy University Hospital, Cork At UEGW in Barcelona in October 2017 Dr. Elsafi and colleagues published a poster entitled “Cost effectiveness of IBDoc as a surrogate marker of mucosal healing in IBD patients post induction of biological agents” This poster described their study…

fCAL turbo vs. IBDoc

Calprotectin Home vs. Laboratory Test

fCAL turbo, IBDoc

Mary O’Connell née Deasy, Biochemistry Department, Mercy University Hospital, Cork, Ireland The Mercy University hospital is one of the largest users of the IBDoc test, with almost 500 patients using the system to monitor their calprotectin levels. It was important to establish the comparative data between results from the patient self test and a laboratory based technology. Mary O’Connell in the…